Pasithea Therapeutics Corp. KTTAW
Set alert
0.00 USD 0.00 0.00%
At close · Sep 16
0.00 0.00 -67.86%
After hours · Sep 16, 4:49 PM ET
0.0027 Day range 0.0028
0.0027 52-week range 0.0028
- YTD
- -72.55%
- 1 year
- -72.55%
- Open
- 0.0122
- Prev close
- 0.0028
- Mkt cap
- 20.84K
- Vol
- 383
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0027
- High
- 0.0028
- Forward P/E
- 0.00
- Beta
- 0.82
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-2.25 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2020 5y median -0.6× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 0.2×
FY 2020 5y median 0.4× FY 2025
P/FCF -0.6×
FY 2020 5y median -0.7× FY 2025
EV/EBITDA 2.3×
FY 2020 5y median 1.4× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -167.7%
FY 2020 5y median -148.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -37.0%
FY 2020 5y median -37.0% FY 2025
ROIC -37.7%
FY 2020 5y median -37.7% FY 2025
ROA -33.9%
FY 2020 5y median -33.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -46.4%
FY 2020 FY 2025
EPS (diluted) 77.1%
FY 2020 FY 2025
Free Cash Flow -9.3%
FY 2020 FY 2025
Financial Health
Current Ratio 11.4×
FY 2020 5y median 11.4× FY 2025
Quick Ratio 11.4×
FY 2020 5y median 11.4× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 2.7×
FY 2020 5y median 2.7× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31